Radiopharmaceuticals, or medicinal radiocompounds or nuclear medicines, are a group of pharmaceutical drugs which have radioactivity. These nuclear medicines can be used for diagnostic as well as therapeutic applications. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these radiocompounds. The main group of these compounds are the radiotracers used to diagnose dysfunction in body tissues. While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs.
Radiopharmaceuticals Market research report is a detailed analysis of the current situation of the industry. An insight study of Radiopharmaceuticals Market done by an industry professional and market experts. This report brings company information, volume, product scope, cost and price of production, profit, demand-supply, import-export activities as well as consumption. It provides the essential marketing methods that cover driving factors, market constraints, opportunities, huge challenges, market share, key players as well as top growing regions.
Ask for a Sample of this Report Now at: http://bit.ly/2VQldyc
- To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Radiopharmaceuticals Market
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
Some of the Major Players In Radiopharmaceuticals Market:
- CARDINAL HEALTH INC.
- GENERAL ELECTRIC COMPANY
- IBA GROUP
- LANTHEUS MEDICAL IMAGING
- COVIDIEN PLC
- POSITRON CORPORATION
- NTP RADIOISOTOPES PTY LTD.
- BRACCO IMAGING
- ADVANCED ACCELERATOR APPLICATIONS
Radiopharmaceuticals Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
The radiopharmaceuticals market is anticipated to grow in the forecast, owing to the factors such increasing incidence and prevalence of target conditions, alpha radioimmunotherapy-based targeted cancer treatment and initiatives to lessen the demand-supply gap of Mo-99 in the market during the forecast period. However short life of the radiopharmaceuticals is hampering the market growth.
The "Global Radiopharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of radiopharmaceuticals market with detailed market segmentation by applications, end user and geography. The global radiopharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radiopharmaceuticals market players and offers key trends and opportunities in the market.
Besides this, the report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South America after evaluating political, economic, social and technological factors effecting the market in these regions.
Radiopharmaceuticals – MARKET SEGMENTATION
- diagnostic applications
- therapeutic applications
By End User
- diagnostic centers
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
The Insight partners,